Edition:
India

Hikma Pharmaceuticals Says US Subsidiary Launches Dexrazoxane For Injection


Friday, 20 Apr 2018 

April 20 (Reuters) - Hikma Pharmaceuticals PLC ::HIKMA LAUNCHES DEXRAZOXANE FOR INJECTION.US SUBSIDIARY WEST-WARD PHARMACEUTICALS, LAUNCHED DEXRAZOXANE FOR INJECTION, 250MG AND 500MG VIALS, GENERIC EQUIVALENT TO ZINECARD.